AbbVie ABBV Deferred Taxes
Deferred Taxes at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.
The official record: AbbVie’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbbVie's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbbVie's deferred taxes?
- AbbVie (ABBV) reported deferred taxes of $2.33B in Q1 2026.
- How has AbbVie's deferred taxes changed year-over-year?
- AbbVie's deferred taxes decreased by 9.7% year-over-year, from $2.58B to $2.33B.
- What is the long-term trend for AbbVie's deferred taxes?
- Over 5 years (2020 to 2025), AbbVie's deferred taxes has grown at a -8.1% compound annual growth rate (CAGR), from $3.65B to $2.39B.
- What does deferred taxes mean?
- This represents the net amount of income taxes that will be payable in future periods due to temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases. It reflects the long-term tax impact of accounting choices and depreciation schedules. Investors use this to understand future tax obligations and the impact of tax timing on cash flow.